Third Harmonic Bio Inc (THRD)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: THRD Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Search

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value	Details
2024-05-10	2024-05-09	PS Planned sale	Holles Natalie C. CEO Executive Director	1,000 -1.6% 12.18 100,000 USD	1,000 -1.6%	12.18	100,000 USD
2024-05-10	2024-05-09	PS Planned sale	Holles Natalie C. CEO Executive Director	1,000 -1.6% 12.18 100,000 USD	1,000 -1.6%	12.18	100,000 USD
2024-04-15	2024-04-11	PS Planned sale	Holles Natalie C. CEO Executive Director	13,558 -1.1% 12.19 165,214 USD	13,558 -1.1%	12.19	165,214 USD
2024-04-08	2024-04-04	PS Planned sale	Person Julie CHIEF ADMINISTRATIVE OFFICER Officer	1,107 -100.0% 10.00 11,070 USD	1,107 -100.0%	10.00	11,070 USD
2023-12-07	2023-12-05	PS Planned sale	Conner Edward R. Chief Medical Officer Officer	4,790 -100.0% 10.03 48,062 USD	4,790 -100.0%	10.03	48,062 USD
2023-12-07	2023-12-05	PS Planned sale	Person Julie Chief Administrative Officer Officer	12,863 -100.0% 10.30 132,484 USD	12,863 -100.0%	10.30	132,484 USD
2022-12-22	2022-12-20	B Purchase	BVF PARTNERS L P/IL Large shareholder	9,597 +4.1% 4.11 39,430 USD	9,597 +4.1%	4.11	39,430 USD
2022-12-22	2022-12-20	B Purchase	BVF PARTNERS L P/IL Large shareholder	87,831 +5.2% 4.11 360,862 USD	87,831 +5.2%	4.11	360,862 USD
2022-12-22	2022-12-20	B Purchase	BVF PARTNERS L P/IL Large shareholder	116,635 +5.3% 4.11 479,207 USD	116,635 +5.3%	4.11	479,207 USD
2022-09-21	2022-09-19	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	300,000 +5.5% 17.00 5,100,000 USD	300,000 +5.5%	17.00	5,100,000 USD
2022-09-21	2022-09-19	B Purchase	Bonita David P Non-Executive Director Large shareholder	300,000 +5.5% 17.00 5,100,000 USD	300,000 +5.5%	17.00	5,100,000 USD
2022-09-19	2022-09-19	B Purchase	Atlas Venture Fund XI, L.P. Large shareholder	300,000 +3.0% 17.00 5,100,000 USD	300,000 +3.0%	17.00	5,100,000 USD